Clinical application of D-dimer in Kawasaki Disease |
Han, Jae Joon
(Department of Pediatrics, College of Medicine, Korea University)
Ko, Hong Ki (Department of Pediatrics, College of Medicine, Korea University) Yoo, Young (Department of Pediatrics, College of Medicine, Korea University) Lee, JungHwa (Department of Pediatrics, College of Medicine, Korea University) Lee, Kwang Chul (Department of Pediatrics, College of Medicine, Korea University) Son, Chang Sung (Department of Pediatrics, College of Medicine, Korea University) Lee, Joo Won (Department of Pediatrics, College of Medicine, Korea University) |
1 | Imamura T, Yoshihara T, Yokoi K, Nakai N, Ishida H, Kasubuchi Y. Impact of increased D-dimer concentrations in Kawasaki disease. Eur J Pediatr 2005;164:526-7 DOI |
2 | Cotran RS, Pober JS. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1990;1:225-35 |
3 | Beckham JC, Caldwell DS, Peterson BL, Pippen AM, Currie MS, Keefe FJ, et al. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. J Clin Immunol 1992;12:353-61 DOI |
4 | Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity Creactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005;111:38-43 DOI ScienceOn |
5 | Hidaka T, Nakano M, Ueta T, Komatsu Y, Yamamoto M. Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease. J Pediatr 1983;102:94-6 DOI |
6 | Sakai M, Asayama K, Otabe T, Kohri T, Shirahata A. Low tissue plasminogen activator relative to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease. Clin Appl Thromb Hemost 2001;7: 214-8 DOI |
7 | Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr 1978;129: 17-27 DOI |
8 | Lin MT, Tsao LY, Cheng ML, Chang YJ, Chiu HY, Chen HN, et al. Absence of hypercoagulability in acute Kawasaki disease. Pediatr Int 2005;47:126-31 DOI ScienceOn |
9 | Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous gammaglobulin treatment in Kawasaki disease. J Pediatr 2000;137: 177-80 DOI ScienceOn |
10 | Burns JC, Glode MP, Clarke SH, Wiggins J, Jr., Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. J Pediatr 1984;105:206-11 DOI |
11 | Hergesell O, Andrassy K, Nawroth P. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost 1996;75:892-8 |
12 | Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE. Plasma D-dimer levels and their relationship to serum fibrinogen/ fibrin degradation products in hypercoagulable states. Br J Haematol 1989;71:65-70 DOI ScienceOn |
13 | Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo 1984 |
14 | Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Jr., Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988;263:5797- 803 |
15 | Brendel-Muller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura. Pediatr Nephrol 2001;16:1084-8 DOI |
16 | Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33 DOI ScienceOn |
17 | de Moerloose P, Desmarais S, Bounameaux H, Reber G, Perrier A, Dupuy G, et al. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism. Thromb Haemost 1996;75:11-3 |
18 | Egermayer P, Town GI, Turner JG, Heaton DC, Mee AL, Beard ME. Usefulness of D-dimer, blood gas, and respiratory rate measurements for excluding pulmonary embolism. Thorax 1998;53:830-4 DOI ScienceOn |
19 | Senzaki H, Kobayashi T, Nagasaka H, Nakano H, Kyo S, Yokote Y, et al. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy. Pediatr Res 2003;53:983-8 DOI ScienceOn |